Right you are and a recent interview with one of the leading pain docs who is one of the Adcom reviewers said, that if it were up to him there would be no new approved NDA opioids until there was something substantially different in the formulation. He did not get into specifics about ADFs; which was a surprise or the result of a bad interviewer not having the right questions.
News 
Market Data 
Discover 
